UBS Group AG - BRIACELL THERAPEUTICS CORP ownership

BRIACELL THERAPEUTICS CORP's ticker is BCTX and the CUSIP is 10778Y302. A total of 28 filers reported holding BRIACELL THERAPEUTICS CORP in Q4 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of BRIACELL THERAPEUTICS CORP
ValueSharesWeighting
Q1 2023$1,259
-87.4%
169
-89.9%
0.00%
Q2 2022$10,000
+233.3%
1,672
+450.0%
0.00%
Q1 2022$3,000
-75.0%
304
-78.3%
0.00%
Q4 2021$12,000
-52.0%
1,402
-54.4%
0.00%
Q3 2021$25,000
-64.8%
3,077
-76.9%
0.00%
Q2 2021$71,000
+3450.0%
13,308
+2005.7%
0.00%
Q1 2021$2,0006320.00%
Other shareholders
BRIACELL THERAPEUTICS CORP shareholders Q4 2021
NameSharesValueWeighting ↓
Redmond Asset Management, LLC 136,593$1,106,0000.35%
Total Clarity Wealth Management, Inc. 11,425$93,0000.04%
Virtu Financial LLC 32,952$267,0000.02%
Apollon Wealth Management, LLC 19,400$157,0000.02%
Summit Trail Advisors, LLC 35,000$284,0000.02%
FNY Investment Advisers, LLC 4,687$37,0000.02%
Freedom Investment Management, Inc. 16,649$135,0000.01%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 156,946$1,271,0000.01%
Belvedere Trading LLC 13,608$107,0000.00%
GOFEN & GLOSSBERG LLC /IL/ 10,000$81,0000.00%
View complete list of BRIACELL THERAPEUTICS CORP shareholders